155 results
Page 5 of 8
8-K
EX-99.1
oovpsxyn
1 Apr 21
EyeGate Pharma Announces the Appointment of Kenneth Gayron and Aron Shapiro to its Board of Directors
6:55am
8-K
EX-99.2
93jmunitd7eg7h
1 Feb 21
Departure of Directors or Certain Officers
6:55am
8-K
EX-99.1
nfja0 0xpitv5
6 Jan 21
EyeGate Enters Into Agreement for $8.0 Million Private Placement
6:55am
8-K
EX-10.1
5kv2mabu
6 Jan 21
EyeGate Enters Into Agreement for $8.0 Million Private Placement
6:55am
8-K
EX-99.1
xqmxjzh4 kn41gka
21 Dec 20
EyeGate Pharma Announces Transformative Acquisition of Panoptes Pharma
6:55am
8-K
EX-2.1
nb88b8bh8z2m
21 Dec 20
EyeGate Pharma Announces Transformative Acquisition of Panoptes Pharma
6:55am
8-K
EX-99.1
g5v2j5o
14 Sep 20
Regulation FD Disclosure
6:50am
8-K
EX-99.1
yo2tb9 hyq4r5xd
1 Jun 20
Regulation FD Disclosure
6:55am
424B5
epyg7b bsx682
31 Dec 19
Prospectus supplement for primary offering
4:28pm
8-K
EX-10.1
eki5o7l9nqslwn6
31 Dec 19
EyeGate Announces $5.0 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
4:05pm
8-K
EX-99.1
cjd36l8ivaj5iie
17 Dec 19
EyeGate Pharma Receives $1.9 Million From Exercised Warrants
8:41am